TOWA PHARMACEUTICAL CO.,LTD. Reports Q3 FY2026 Earnings Presentation
Source disclosure: February 13, 2026 TOWA PHARMACEUTICAL CO.,LTD. [4553.T] TOKYO, Feb 13 (Pulse News Wire) – TOWA PHARMACEUTICAL CO.,LTD. (4553.T) released its earnings presentation for Q3 FY2026. Revenue was ¥10 billion. Operating profit was ¥960 million. Ordinary profit was ¥1.18 billion. Net profit was ¥840 million. Total assets stood at ¥190 billion. AI-translated content. 🟢 Confidence: High See terms • Original filing 💬 Help us improve translation quality Notice
Source disclosure: February 13, 2026
TOWA PHARMACEUTICAL CO.,LTD. [4553.T]
TOKYO, Feb 13 (Pulse News Wire) – TOWA PHARMACEUTICAL CO.,LTD. (4553.T) released its earnings presentation for Q3 FY2026.
18 billion.
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms • Original filing